Location History:
- Richmond, CA (2001 - 2003)
- Monrovia, CA (US) (2004 - 2008)
- Lowell, MA (US) (2012 - 2018)
Company Filing History:
Years Active: 2001-2018
Title: Innovative Contributions of Timothy J. Krieger in Biotechnology
Introduction
Timothy J. Krieger, based in Lowell, MA, is a notable inventor whose contributions to the field of biotechnology have led to the development of twelve patents. His work primarily focuses on the creation of antimicrobial and anti-inflammatory peptide compositions, which hold significant promise for the treatment of various diseases.
Latest Patents
Among his latest patents, Krieger has developed compositions that encompass antimicrobial and anti-inflammatory peptide formulations. These compositions are designed for therapeutic uses, targeting inflammatory diseases caused by microorganisms, such as infections, acne, and psoriasis. His innovative peptides, particularly cationic peptides, can be applied topically or through parenteral methods, making them versatile in medical applications. Additionally, he has patented therapeutic formulations specifically utilizing antimicrobial cationic peptides, which are effective in treating both systemic and localized infections, including septicemia and infections associated with implanted medical devices.
Career Highlights
Krieger's career includes significant tenures at Carrus Capital Corporation and Micrologix Biotech Inc., where he leveraged his expertise to advance biotechnology solutions. His innovative spirit has earned him recognition in the scientific community, contributing to the evolution of therapeutic approaches in health care.
Collaborations
Throughout his career, Timothy J. Krieger has collaborated with esteemed professionals like Patricia J. McNicol and Janet R. Fraser. These partnerships have enriched his research endeavors and facilitated the development of his patented technologies, fostering an environment of innovation and excellence.
Conclusion
Timothy J. Krieger's contributions to biotechnology through his inventive work on antimicrobial and anti-inflammatory peptides illustrate his significant impact on medical science. His patented technologies promise to improve treatment options for a variety of inflammatory diseases, confirming his place as a leading inventor in the field.